Prevention of irinotecan plus5-fluorouracil/leucovorin-induced diarrhoea by oral administration of neomycin plus bacitracin in first-line treatment of advanced colorectal cancer-Reference-Cited by-同舟云学术

Prevention of irinotecan plus5-fluorouracil/leucovorin-induced diarrhoea by oral administration of neomycin plus bacitracin in first-line treatment of advanced colorectal cancer

Published:2003-05 Issue:5 Volume:14 Page:805
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Alimonti A.,Satta F.,Pavese I.,Burattini E.,Zoffoli V.,Vecchione A.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/14/5/805/567039/mdg193.pdf

Reference5 articles.

1. Irinotecan (CPT-11) metabolism and disposition in cancer patients;Sparreboom;Clin Cancer Res,1998

2. Pharmacokinetic interrelationships of irinotecan (CPT-11) and its three major plasma metabolites in patients enrolled in phase I/II trials;Rivory;Clin Cancer Res,1997

3. Metabolic fate of irinotecan in humans: correlation of glucuronidation with diarrhea;Gupta;Cancer Res,1994

4. Inhibition of intestinal microflora beta-glucuronidase modifies the distribution of the active metabolite of the antitumor agent, irinotecan hydrochloride (CPT-11) in rats;Takasuna;Cancer Chemother Pharmacol,1998

5. Modulation of irinotecan-induced diarrhea by cotreatment with neomycin in cancer patients;Kehrer;Clin Cancer Res,2001

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemotherapy-induced gastrointestinal toxicity: Pathogenesis and current management;Biochemical Pharmacology;2023-10

2. Microbiota-Host-Irinotecan Axis: A New Insight Toward Irinotecan Chemotherapy;Frontiers in Cellular and Infection Microbiology;2021-10-14

3. Pitfalls and novel experimental approaches to optimize microbial interventions for chemotherapy-induced gastrointestinal mucositis;Current Opinion in Supportive & Palliative Care;2020-06

4. A randomized controlled, open‐label early phase II trial comparing incidence of FOLFIRI.3‐induced diarrhoea between Hangeshashinto and oral alkalization in Japanese patients with colorectal cancer;Journal of Clinical Pharmacy and Therapeutics;2019-08-13

5. The bidirectional interaction of the gut microbiome and the innate immune system: Implications for chemotherapy‐induced gastrointestinal toxicity;International Journal of Cancer;2018-10